Role of circular RNA in neurological disease

Role of circular RNA in neurological disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Detalhes bibliográficos
Autor principal:	Salsabil, Labiba
Outros Autores:	Chowdhury, Namara Mariam
Formato:	Thesis
Idioma:	English
Publicado em:	Brac University 2024
Assuntos:	Circular RNA circRNA Neurological disorder Alzheimer’s disease Parkinson’s disease Nervous system > Diseases. Molecular neurobiology.
Acesso em linha:	http://hdl.handle.net/10361/23932

Registos relacionados

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
Por: Dey, Manashi
Publicado em: (2024)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
Por: Halim, Rabea
Publicado em: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
Por: Zaman, Rubaiyat
Publicado em: (2024)

Targeting circular RNA for cardiovascular diseases
Por: Sarkar, Deepannita
Publicado em: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
Por: Bakar, Osama Bin Abu
Publicado em: (2024)

RNA drugs and RNA targets for small molecules: Prospects and challenges
Por: Islam, Md. Raihanul
Publicado em: (2024)

Implications of unusual non-coding RNAs in human diseases
Por: Ahmed, Tazkia
Publicado em: (2021)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
Por: Mostofa, Golam
Publicado em: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
Por: Chowdhury, Sariya Uzrat
Publicado em: (2022)

A review on optogenetics and its potential in neurological disorder management
Por: Armin, Fariza
Publicado em: (2024)

A computational approach to design putative potential siRNAs for silencing the nucleoprotein and surface glycoprotein gene of MARV
Por: Suraiya, Tasnia Iffat
Publicado em: (2023)

Gene editing for neurodegenerative diseases-A review
Por: Sharna, Anika Islam
Publicado em: (2023)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
Por: Ferdous, Labiba
Publicado em: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Por: Alim, Abdul
Publicado em: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
Por: Annee, Israt Jahan
Publicado em: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
Por: Tasneem, Sadia
Publicado em: (2021)

A review paper on developing novel antiviral strategies against pathogenic RNA viruses
Por: Nawar, Numia
Publicado em: (2021)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
Por: Tabassum, Nadira
Publicado em: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
Por: Afsana, Nourin
Publicado em: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
Por: Islam, Md. Irfath
Publicado em: (2023)

Unlocking the therapeutic potential of RNA: a comprehensive review of RNA-based therapy
Por: Ahmad, Rafid Uddin, et al.
Publicado em: (2024)

Role of voltage-gated sodium channel modulators in peripheral nervous system disorders
Por: Mithila, Sabekun Nahar
Publicado em: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
Por: Shehab, Habibul Mohsin
Publicado em: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
Por: Mahaleka, Aarshi
Publicado em: (2024)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
Por: Islam, Md. Rakibul
Publicado em: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
Por: Aziz, Farhin
Publicado em: (2019)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
Por: Karmaker, Swastika
Publicado em: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
Por: Key, Nasrin Sultana
Publicado em: (2023)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
Por: Rawshan, A. E. Maisha
Publicado em: (2022)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
Por: Ishrat, Nowshin
Publicado em: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
Por: Saha, Bithi Rani
Publicado em: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
Por: Chowdhury, Amal
Publicado em: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
Por: Afreen, Nuraia
Publicado em: (2021)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
Por: Hassan, Md. Muhtaz
Publicado em: (2020)

Review on: the mechanism and function of Glia in parkinson's disease
Por: Abedin, Khondokar Mezbahul
Publicado em: (2023)

A review on the role of Myc and miRNA in Glioblastoma multiforme
Por: Naureen, Ishrat
Publicado em: (2022)

Alzheimer's disease and marriage : an intimate account /
Por: Wright, Lore K.
Publicado em: (1993)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
Por: Tamanna, Mst. Taskia
Publicado em: (2023)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
Por: Nuha, Nabiha Tahsin
Publicado em: (2024)

Detection of Parkinson’s disease from Neuro-imagery using deep neural network with transfer learning
Por: Asaduzzaman, et al.
Publicado em: (2021)